Arbizu, Javier http://orcid.org/0000-0002-8370-5510
,
Festari, Cristina
Altomare, Daniele
Walker, Zuzana
Bouwman, Femke
Rivolta, Jasmine
Orini, Stefania
Barthel, Henryk
Agosta, Federica
Drzezga, Alexander
Nestor, Peter
Boccardi, Marina
Frisoni, Giovanni Battista
Nobili, Flavio
Article History
Received: 14 April 2018
Accepted: 19 April 2018
First Online: 27 April 2018
Compliance with ethical standards
:
: Javier Arbizu: received grants from Eli-Lilly & Co, Piramal and GE Healthcare.Cristina Festari: declares that she has no conflict of interest.Daniele Altomare was the recipient of the grant allocated by the European Academy of Neurology (EAN) for data extraction and evidence assessment for the present project.Zuzana Walker: received from G.E. Healthcare grants and tracers, personal fees for consultancy and speakers fee.Femke Bouwman: declares that she has no conflict of interest.Jasmine Rivolta: declares that she has no conflict of interest.Stefania Orini: declares that she has no conflict of interest.Henrik Barthel: declares that he has no conflict of interest.Federica Agosta: is Section Editor of NeuroImage: Clinical; has received speaker fees from Biogen Idec, Novartis, and Excellence in Medical Education; and receives or has received research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and the European Research Council. She received personal fees from Elsevier Inc.Alexander Drzezga: received grants and non-financial support from Eli-Lilly & Co, Siemens and GE Healthcare; he also received non-financial support from Piramal.Peter Nestor: received radiotracer from Piramal at a discounted rate as part of a research collaboration.Marina Boccardi has received funds from the European Association of Nuclear Medicine (EANM) to perform the evidence assessment and the global coordination of the present project. Moreover, she has received research grants from Piramal and served as a paid member of advisory boards for Eli Lilly.Giovanni B Frisoni is principal investigator of industry-sponsored trials funded by AbbVie, Acadia, Altoida, Amoneta, Araclon, Biogen, Janssen, Novartis, Piramal; has received funding for investigator-initiated trials from GE, Piramal, and Avid-Lilly; and has received speaker fees from a number of pharma and imaging companies.Flavio Nobili: received personal fees and non-financial support from GE Healthcare, non-financial support from Eli-Lilly and grants from Chiesi Farmaceutici.
: This is a review article that does not contain any original study with human participants performed by any of the authors. Ethical approval is shown in each of the quoted original papers.
: not applicable, this is a review article. Informed consent statement is declared in each of the revised papers.